Q32 Bio Inc (QTTB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 77,965 | 25,617 | 33,986 | 108,382 | 217,431 |
| Marketable Securities | N/A | N/A | 141,040 | 47,491 | 0 |
| Other current assets | 0 | 0 | 0 | 28,907 | 0 |
| TOTAL | $81,877 | $28,716 | $181,015 | $191,909 | $219,564 |
| Non-Current Assets | |||||
| PPE Net | 1,370 | 1,782 | 1,078 | 2,252 | 37,002 |
| Investments And Advances | 2,600 | 0 | 25,814 | 0 | 0 |
| Other Non-Current Assets | 6,485 | 16,559 | 20,563 | 17,560 | 7,171 |
| TOTAL | $10,455 | $18,341 | $47,455 | $19,812 | $44,173 |
| Total Assets | $92,332 | $47,057 | $228,470 | $211,721 | $263,737 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,097 | 878 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 2,989 | 3,468 | 1,144 | 2,366 | 4,722 |
| Accrued Expenses | 7,479 | 9,763 | 18,715 | 11,406 | 9,803 |
| Other current liabilities | 2,900 | N/A | N/A | N/A | N/A |
| TOTAL | $16,465 | $14,109 | $22,576 | $17,226 | $22,658 |
| Non-Current Liabilities | |||||
| Long Term Debt | 9,556 | 4,581 | N/A | N/A | N/A |
| Deferred Revenues | N/A | N/A | 1,156 | 3,208 | 5,632 |
| Other Non-Current Liabilities | 60,636 | 99,843 | 27,916 | 23,688 | 12,941 |
| TOTAL | $70,192 | $104,424 | $27,916 | $24,844 | $45,084 |
| Total Liabilities | $86,657 | $118,533 | $50,492 | $42,070 | $67,742 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 12,198 | 663 | 3,207 | 3,191 | 2,807 |
| Common Shares | 2 | 1 | 6 | 6 | 5 |
| Retained earnings | -234,814 | -187,081 | -429,137 | -424,132 | -328,368 |
| Other shareholders' equity | 0 | 111,445 | -404 | -7 | 0 |
| TOTAL | $5,675 | $-71,476 | $177,978 | $169,651 | $195,995 |
| Total Liabilities And Equity | $92,332 | $47,057 | $228,470 | $211,721 | $263,737 |